Fluence by OSRAM Experts Join Speaker Lineups at Global Horticulture and Cannabis Conferences This Fall
23.9.2021 18:54:00 EEST | Business Wire | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced its upcoming schedule of speakers who will present at virtual and in-person horticulture and cannabis industry conferences this fall.
“We’re thrilled our speakers are joining industry thought leaders from across the world to share their deep knowledge with cultivators, researchers, partners and others,” said David Cohen, CEO of Fluence. “At Fluence, our experts lead with science and are dedicated to advancing the industry’s awareness and application of LED lighting technologies to better understand the interaction between light and life. We look forward to connecting with conference participants, engaging in valuable conversations and discussing insights and learnings about what’s possible for LED lighting technology.”
Fluence’s roster of speakers includes:
- NCIA’s Midwest Cannabis Business Conference: Corinne Wilder, vice president of global operations, will speak with Dario Boyce from Anderson Porter Design and Jesse Porter from Inspire Transpiration Solutions on Sept. 23 at 12:00 p.m. CST about guidelines and policy for resource efficiency, including HVAC, lighting and control systems.
- NYC AgTech Week: Steve Graves, vice president of business development, will speak with Alina Zolotareva from AeroFarms, Tisha Livingston from Infinite Acres, Dr. Mary Ellis from Earle & Associates Ltd. and Penny McBride from FarmTech Society on Sept. 24 at 1:45 p.m. CST about trends in global controlled environment agriculture.
-
GreenTech Amsterdam:
- Timo Bongartz, general manager of EMEA, will speak with Brad Nattrass from urban-gro and Nic Easley from 3C Consulting, LLC on Sept. 29 at 8:00 a.m. CST about market insights, challenges and opportunities for medical cannabis.
- Leo Lansbergen, horticulture service specialist, will speak with Max van den Hemel from Delphy Improvement Centre, Marc van Oers from Van Iperen International and Eri Hayashi from the Japan Plant Factory Association on Sept. 28 at 5:15 a.m. CST about crop management and optimization.
- Theo Tekstra, technical director, will speak with Lisanne Meulendijks from Delphy Improvement Centre, Andrew Jenkins from TU Delft and Aleksander Nastov from Samsung on Sept. 29 at 7:00 a.m. CST about vertical farming.
- HortiCann Light + Tech: Dr. Abhay Thosar, director of horticulture services, will speak with Adam Shinners from Superior Fresh on Sept. 29 at 3:00 p.m. CST about sustainability and best cultivation practices, efficiencies and optimized lighting strategies in commercial food production.
- Indoor Ag-Con: Steve Graves, vice president of business development, will participate in a panel on Oct. 4 at 9:30 a.m. CST about the next technical frontier for lighting.
- Benzinga Cannabis Capital Conference: David Cohen, CEO of Fluence, will give an exclusive on-stage interview during Benzinga’s hybrid event on Oct. 15 at 12:10 p.m. CST.
- MJBizCon: Corinne Wilder, vice president of global operations, will speak with David Hess from Tress Capital and Derek Smith from the Resource Innovation Institute on Oct. 22 at 12:30 p.m. CST about environmental and sustainability practices.
- 2021 Plant Lighting Short Course: Dr. David Hawley, principal scientist, will speak on Oct. 28 at 1:00 p.m. CST about lighting for indoor agriculture.
- Grow Up Conference & Expo: Taylor Kirk, horticulture service specialist, will join cannabis experts on Dec. 1 at 9:15 a.m. CST to discuss growers’ experiences and expectations with LED lighting in cannabis cultivation.
For information about Fluence’s upcoming speaking engagements, including more presentation details, how to register and how to contact the Fluence team at their upcoming conferences, visit www.fluence.science/events-main.
About Fluence by OSRAM
Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM, creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. For more information about Fluence, visit www.fluence.science.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210923005773/en/
Contact information
Media Contact:
For Fluence, Pam Olszewski
pr@fluencebioengineering.com
C: 512-662-8551
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
